Company Name: Strongbridge Biopharma plc
Strongbridge Biopharma is a biopharmaceutical company. The company is engaged in acquiring, developing and in-licensing products designed to treat rare diseases with a primary focus on rare endocrine disorders. The company’s pipeline includes product candidates designed to treat acromegaly and endogenous Cushing’s syndrome.
Ticker Symbol: SBBP (NASDAQ)
Company Website: www.strongbridgebio.com
Headquarters: Trevose, PA